| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |